Literature DB >> 22422187

MR imaging of papilledema and visual pathways: effects of increased intracranial pressure and pathophysiologic mechanisms.

N Passi1, A J Degnan, L M Levy.   

Abstract

Papilledema, defined as swelling of the optic disc, frequently occurs in the setting of increased ICP and in a variety of medical conditions, including pseudotumor cerebri, sinus thrombosis, intracerebral hemorrhage, frontal lobe neoplasms, and Chiari malformation. Noninvasive imaging of the ON is possible by using MR imaging, with a variety of findings occurring in the setting of papilledema, including flattening of the posterior sclera, protrusion of the optic disc, widening of the ONS, and tortuosity of the ON. Early recognition of papilledema and elevated ICP is of paramount importance for ensuring restoration of vision. Newer advanced MR imaging techniques such as fMRI and DTI may prove useful in the future to assess the potential effects of papilledema on retinal and visual pathway integrity.

Entities:  

Mesh:

Year:  2012        PMID: 22422187      PMCID: PMC7964659          DOI: 10.3174/ajnr.A3022

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  62 in total

1.  THE PROGNOSIS IN PAPILLOEDEMA.

Authors:  G Holmes
Journal:  Br J Ophthalmol       Date:  1937-07       Impact factor: 4.638

2.  Visual loss without papilledema in idiopathic intracranial hypertension.

Authors:  Matthew J Thurtell; Nancy J Newman; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2010-03       Impact factor: 3.042

3.  MRI of the optic nerve in benign intracranial hypertension.

Authors:  A Gass; G J Barker; P Riordan-Eva; D MacManus; M Sanders; P S Tofts; W I McDonald; I F Moseley; D H Miller
Journal:  Neuroradiology       Date:  1996-11       Impact factor: 2.804

4.  The findings of standardized echography for choroidal folds.

Authors:  H R Atta; S F Byrne
Journal:  Arch Ophthalmol       Date:  1988-09

5.  Papilledema: the vexing issues.

Authors:  Jonathan D Trobe
Journal:  J Neuroophthalmol       Date:  2011-06       Impact factor: 3.042

6.  Identifying the human optic radiation using diffusion imaging and fiber tractography.

Authors:  Anthony J Sherbondy; Robert F Dougherty; Sandy Napel; Brian A Wandell
Journal:  J Vis       Date:  2008-12-17       Impact factor: 2.240

7.  Retrobulbar optic nerve diameter measured by high-speed magnetic resonance imaging as a biomarker for axonal loss in glaucomatous optic atrophy.

Authors:  Wolf A Lagrèze; Mirjam Gaggl; Matthias Weigel; Jürgen Schulte-Mönting; Anima Bühler; Michael Bach; Robin D Munk; Thorsten A Bley
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-30       Impact factor: 4.799

8.  Diffusion tensor imaging in acquired blind humans.

Authors:  F Schoth; U Burgel; R Dorsch; M H T Reinges; T Krings
Journal:  Neurosci Lett       Date:  2006-02-08       Impact factor: 3.046

Review 9.  Idiopathic intracranial hypertension.

Authors:  Devin K Binder; Jonathan C Horton; Michael T Lawton; Michael W McDermott
Journal:  Neurosurgery       Date:  2004-03       Impact factor: 4.654

10.  Magnetic resonance imaging in pseudotumor cerebri.

Authors:  M C Brodsky; M Vaphiades
Journal:  Ophthalmology       Date:  1998-09       Impact factor: 12.079

View more
  26 in total

1.  Automated quantitation of the posterior scleral flattening and optic nerve protrusion by MRI in idiopathic intracranial hypertension.

Authors:  N Alperin; A M Bagci; B L Lam; E Sklar
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

2.  Diagnostic value of neuro-ophthalmological signs in cases of Chiari I malformation.

Authors:  Inessa Bekerman; Tal Sigal; Itzhak Kimiagar; Zina Evy Almer; Michael Vaiman
Journal:  Childs Nerv Syst       Date:  2016-11-08       Impact factor: 1.475

3.  Diffusion tensor imaging of the optic disc in idiopathic intracranial hypertension.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nihal Batouty; Wesam Fathy; Rania Bassiouny
Journal:  Neuroradiology       Date:  2018-08-22       Impact factor: 2.804

4.  The efficacy of orbital ultrasonography and magnetic resonance imaging findings with direct measurement of intracranial pressure in distinguishing papilledema from pseudopapilledema.

Authors:  Zeynep Ozturk; Tuba Atalay; Ebru Arhan; Kursad Aydin; Ayse Serdaroglu; Tugba Hirfanoglu; Cengiz Havali; Yilmaz Akbas; Duygu Yalinbas
Journal:  Childs Nerv Syst       Date:  2017-05-22       Impact factor: 1.475

5.  Optic nerve sheath diameters in healthy adults measured by computer tomography.

Authors:  Michael Vaiman; Rani Abuita; Inessa Bekerman
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

6.  Subarachnoid space of the optic nerve sheath and intracranial hypertension: a macroscopic, light and electron microscopic study.

Authors:  A Durouchoux; D Liguoro; M Sesay; L Le Petit; V Jecko
Journal:  Surg Radiol Anat       Date:  2022-05-04       Impact factor: 1.246

7.  Lyme disease-related intracranial hypertension in children: clinical and imaging findings.

Authors:  Sriram Ramgopal; Rawad Obeid; Giulio Zuccoli; Catalina Cleves-Bayon; Andrew Nowalk
Journal:  J Neurol       Date:  2016-01-06       Impact factor: 4.849

8.  Hyperintense optic nerve heads on diffusion-weighted imaging: a potential imaging sign of papilledema.

Authors:  R Viets; M Parsons; G Van Stavern; C Hildebolt; A Sharma
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

9.  Visual outcome after endoscopic third ventriculostomy for hydrocephalus.

Authors:  Ji-Ho Jung; Yong-Hyun Chai; Shin Jung; In-Young Kim; Woo-Youl Jang; Kyung-Sub Moon; Seul-Kee Kim; Sangjoon Chong; Seung-Ki Kim; Tae-Young Jung
Journal:  Childs Nerv Syst       Date:  2017-11-03       Impact factor: 1.475

10.  Magnetic Resonance Imaging Features and Clinical Findings in Pediatric Idiopathic Intracranial Hypertension: A Case-Control Study.

Authors:  Aubrey L Gilbert; Jennifer Vaughn; Sarah Whitecross; Caroline D Robson; David Zurakowski; Gena Heidary
Journal:  Life (Basel)       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.